Current vaccine adjuvants: an overview of a diverse class

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article

Charlotte Read Kensil¹, Annie Xiaoyan Mo¹, Alemseged Truneh^1,*

Show Less

¹ Antigenics, Inc., 3 Forbes Road, Lexington, MA 02421

Front. Biosci. (Landmark Ed) 2004, 9(5), 2972–2988; https://doi.org/10.2741/1452

Published: 1 September 2004

Download PDF

Cite

Abstract

Numerous compounds are under evaluation as immunological adjuvants for improvement of vaccine performance. This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclinical and clinical studies.

Previous article in this issue

Next article in this issue

Front. Biosci. (Landmark Ed) Print ISSN 2768-6701 Electronic ISSN 2768-6698